Literature DB >> 29316009

Excess incidence and risk factors for recurrent pneumonia in bipolar disorder.

Min-Shan Li1, Galen Chin-Lun Hung1,2, Shu-Yu Yang1,3, Chun-Hung Pan1,4, Ya-Tang Liao5, Shang-Ying Tsai6,7, Chiao-Chicy Chen6,7,8, Chian-Jue Kuo1,6,7.   

Abstract

AIM: Patients with bipolar disorder (BD) tend to have poorer outcomes after pneumonia and could have a higher risk for recurrence of pneumonia. We aimed to investigate the incidence and risk factors of recurrent pneumonia in patients with BD.
METHODS: In a nationwide cohort of BD patients (derived from the National Health Insurance Research Database in Taiwan) who were hospitalized for pneumonia between 1996 and 2012, we identified 188 patients who developed recurrent pneumonia after a baseline pneumonia episode. Applying risk-set sampling at a 1:2 ratio, 353 matched controls were selected from the study cohort. We used multivariate conditional logistic regression analysis to explore the association between recurrent pneumonia and physical illness, concomitant medications, and psychotropic drugs.
RESULTS: The findings showed that the incidence of recurrent pneumonia in BD was 6.60 cases per 100 person-years, which was higher than that in the general population. About 10% (9.24%) of cases with recurrent pneumonia died within 30 days of hospitalization. Patients had increased risk of recurrent pneumonia if they had hypertension, diabetes mellitus, cancer, or asthma. Conversely, psychotropic drugs, both first- and second-generation antipsychotics, which are known to increase susceptibility to baseline pneumonia, were not associated with risk of pneumonia recurrence.
CONCLUSION: We found an excess incidence of recurring pneumonia in patients with BD, and this risk was associated with pre-existing medical conditions but not psychotropic agents. Physicians should carefully consider the comorbid medical conditions of patients with BD that could lead to recurrent pneumonia.
© 2018 The Authors. Psychiatry and Clinical Neurosciences © 2018 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  antipsychotics; bipolar disorder; mood stabilizers; recurrent pneumonia; risk factors

Mesh:

Substances:

Year:  2018        PMID: 29316009     DOI: 10.1111/pcn.12636

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  2 in total

1.  Clinical efficacy enhancement of a Chinese herbal injection in the treatment of mycoplasma pneumonia in children: A protocol of randomized controlled trial.

Authors:  Mian Wang; Hongying Li; Jialing Yang; Meng Wang; Jie Liu
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

2.  Assessment of levels of D-dimer and interferon-γ in pediatric patients with Mycoplasma pneumoniae pneumonia and its clinical implication.

Authors:  Xiaoqiu Jin; Ying Zhu; Yingchun Zhang; Jing Chen; Li Rong; Xuesong Zhao
Journal:  Exp Ther Med       Date:  2018-10-17       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.